🔎 Trials Near Me

Akèy › Adenokasinom Ezofajyen › Maryland

Etid klinik pou Adenokasinom Ezofajyen nan Maryland

6 etid pou Adenokasinom Ezofajyen ap chèche patisipan nan sit nan Maryland.

Vil nan Maryland

Tèks ofisyèl etid la (Anglè)

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

  • UPMC Western Maryland, Cumberland
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • Christiana Care - Union Hospital, Elkton
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05677490

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

  • Maryland Oncology Hematology, P.A., Annapolis
  • Maryland Oncology Hematology, P.A., Bethesda
  • Maryland Oncology Hematology, P.A., Brandywine
  • ak 5 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07392892

Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms

  • Johns Hopkins Hospital, Baltimore
Ap rekriteVolontè an sante akeyi
Laj 50 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06687603

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

  • Johns Hopkins Universtiy, Baltimore
Ap rekrite
Laj 18 a 89 · Tout sèks · Mizajou Sep 11, 2026 · NCT05753748

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

  • Research Site, Silver Spring
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07431281

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.